New Microbes and New InfectionsBackground: Plasmodium vivax malaria has long been considered less severe than P. falciparum infection. However, there is growing evidence that P. vivax can lead to severe and life-threatening disease, although its burden is likely to be underestimated ...
Livia Bresciani +16 more
doaj +2 more sources
Rising burden of Plasmodium vivax in Mizoram: an emerging threat to malaria elimination in Northeast India [PDF]
BMC Infectious DiseasesBackground India has made tremendous progress in malaria elimination efforts; however, several malaria pockets with high transmission remain that require continuous focus.
C. Vanlalhriata +9 more
doaj +2 more sources
Role of the spleen in Plasmodium vivax: a reticulocyte-prone non-lethal malaria [PDF]
, 2012 “Plasmodium vivax” és el paràsit causant de malària humana amb més àmplia distribució i és responsable cada any de 100-300 milions de casos clinics, incloent algunes manifestacions severes i mort. P.
Ferrer Almirall, Mireia
core +7 more sources
Village malaria workers for the community-based management of vivax malaria
The Lancet Regional Health - Southeast Asia, 2023 Summary: In Cambodia, malaria cases are on a trajectory towards the goal of malaria elimination by 2025. Vivax malaria is difficult to eliminate because of hypnozoites that can cause relapse.
Bipin Adhikari +6 more
doaj +1 more source
Vivax Malaria Presenting with Myelitis: A Rare Complication [PDF]
Journal of Clinical and Diagnostic Research, 2013 Neurological complications may occur with the Plasmodium falciparum infection. However, the association of neurological manifestations with vivax malaria remains doubtful. Of late, there are isolated case reports/studies which have implicated P.
Avijit Moulick +4 more
doaj +1 more source
Rising report of Plasmodium vivax in sub-Saharan Africa: Implications for malaria elimination agenda
Scientific African, 2020 Plasmodium vivax and P. falciparum are the most important human malaria species. P. falciparum is considered the most virulent and widespread species in sub-Saharan Africa.
Mary Aigbiremo Oboh +5 more
doaj +1 more source
Clinical impact of vivax malaria: A collection review.
PLoS Medicine, 2022 BackgroundPlasmodium vivax infects an estimated 7 million people every year. Previously, vivax malaria was perceived as a benign condition, particularly when compared to falciparum malaria.
Aung Pyae Phyo +3 more
doaj +1 more source
Autoantibodies to Extracellular Erythrocyte Band 3 Epitopes Are Associated With Anemia in Plasmodium vivax Infection. [PDF]
Am J HematolABSTRACT Plasmodium vivax‐associated anemia is a multifactorial clinical outcome, in which the destruction of uninfected red blood cells (uRBCs) plays a major role in disease development and severity. Here, we identified autoantibody targets within the extracellular loops of Band 3 (B3), a major erythrocyte transmembrane protein.
Marzano-Miranda A +6 more
europepmc +2 more sources
Insights into the elimination of vivax malaria in China
Infectious Diseases of Poverty, 2023 Background Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics.
Fang Huang, Li Zhang, Zhi-Gui Xia
doaj +1 more source
Malaria-Associated Secondary Hematophagocytic Lymphohistocytosis-A Case Report and Comprehensive Literature Review (sHLH). [PDF]
Clin Case RepABSTRACT Malaria‐associated secondary HLH, though rare, is often overlooked. Clinicians should maintain a high‐index of suspicion in travelers returning from malaria‐endemic regions who develop severe to rapidly worsening inflammatory illness, as early recognition is critical for survival.
Yadav I +4 more
europepmc +2 more sources